Cuproptosis/Apoptosis Co-Activated Immunogenic Cell Death Mediated by a Copper-Based Nanozyme
The highly immunosuppressive tumor microenvironment significantly restricts T-cellmediated antitumor responses, thereby severely limiting the efficacy of immunotherapy.Herein, a mitochondria-targeted nanozyme platform rich in copper ions is rationally designed and engineered for cuproptosis/apoptosis co-activated immunogenic cell death (ICD), and subsequently enhances immunotherapy.In this structure, the disulfiram-copper complex leverages its unique transmembrane transport capability to precisely deliver copper ions into the tumor cells, facilitating the in situ concurrent cuproptosis and apoptosis via mitochondrial dysfunction and enhanced oxidative stress.This combined induction of cuproptosis and apoptosis triggers a pronounced ICD, evidenced by the significant release of DAMPs, such as CRT, HMGB1, and ATP.These signals promote dendritic cell maturation, antigen presentation, and cytotoxic T lymphocyte activation, collectively reprogramming the immunosuppressive tumor microenvironment into an immune activation state.Moreover, the system strategically leverages therapy-induced upregulation of PD-L1 to potentiate immune checkpoint blockade.When integrated with αPD-1 treatment, the rate of tumor suppression attained 96.8%, significantly exceeding the 49.2% effectiveness observed with αPD-1 monotherapy.Therefore, the immunostimulatory strategy that leverages cuproptosis to modulate the tumor microenvironment represents an innovative and promising approach that can effectively enhance the efficacy of immune response in cancer immunotherapy.
Authors
- Yunhao Zhang (ORCID: https://orcid.org/0009-0001-7507-4552)
- Chen Dong
- Yanqiang Yang
- xiaoqun ye
- Xinyi Zhang
- Xuehua Ma
- Yuan Xu
- Tianxiang Chen
- Aiguo Wu
- Changyong Gao
Institutions
- Nanchang University (CN)
- Ningbo University of Finance & Economics (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Second Hospital of Nanchang (CN)
- Ningbo Institute of Industrial Technology (CN)
Publication Details
- Journal
- Cyborg and Bionic Systems
- Published
- 2026-11-18
- DOI
- https://doi.org/10.34133/cbsystems.0772
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Nanchang University
- Natural Science Foundation of Ningbo